December 20, 2011
GlaxoSmithKline K.K. (GSK) announced on December 19 that the company filed on December 15 an application for an additional indication for its Botox injection (botulinum toxin type A) for the treatment of axillary hyperhidrosis with the Ministry of Health, Labor...read more